Depreciation of CHINA PHARMA HOLDINGS, INC. from 31 Dec 2014 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
CHINA PHARMA HOLDINGS, INC. quarterly and annual Depreciation in USD history and change rate from 31 Dec 2014 to 30 Sep 2025.
  • CHINA PHARMA HOLDINGS, INC. Depreciation for the quarter ending 30 Sep 2025 was $158,076, a 68% decline year-over-year.
  • CHINA PHARMA HOLDINGS, INC. Depreciation for the twelve months ending 30 Sep 2025 was $897,378, a 62% decline year-over-year.
  • CHINA PHARMA HOLDINGS, INC. annual Depreciation for 2024 was $2,170,820, a 14% decline from 2023.
  • CHINA PHARMA HOLDINGS, INC. annual Depreciation for 2023 was $2,529,857, a 5% decline from 2022.
  • CHINA PHARMA HOLDINGS, INC. annual Depreciation for 2022 was $2,663,975, a 13% decline from 2021.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

CHINA PHARMA HOLDINGS, INC. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $897,378 $158,076 -$335,104 -68% 01 Jul 2025 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 $1,232,482 $163,503 -$473,218 -74% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 $1,705,700 $171,601 -$465,120 -73% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 $2,170,820 $404,198 -$213,122 -35% 01 Oct 2024 31 Dec 2024 10-K 31 Mar 2025 2024 FY
Q3 2024 $2,383,942 $493,180 -$137,399 -22% 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2025 2025 Q3
Q2 2024 $2,521,341 $636,721 -$4,258 -0.66% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025 2025 Q2
Q1 2024 $2,525,599 $636,721 -$4,258 -0.66% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025 2025 Q1
Q4 2023 $2,529,857 $617,320 -$43,407 -6.6% 01 Oct 2023 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 $2,573,264 $630,579 -$24,807 -3.8% 01 Jul 2023 30 Sep 2023 10-Q 13 Nov 2024 2024 Q3
Q2 2023 $2,598,071 $640,979 -$32,952 -4.9% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2024 2024 Q2
Q1 2023 $2,631,023 $640,979 -$32,952 -4.9% 01 Jan 2023 31 Mar 2023 10-Q 14 Aug 2023 2023 Q2
Q4 2022 $2,663,975 $660,727 -$40,373 -5.8% 01 Oct 2022 31 Dec 2022 10-K 01 Apr 2024 2023 FY
Q3 2022 $2,704,348 $655,386 -$311,570 -32% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023 2023 Q3
Q2 2022 $3,015,918 $673,931 -$17,012 -2.5% 01 Apr 2022 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 $3,032,930 $673,931 -$16,776 -2.4% 01 Jan 2022 31 Mar 2022 10-Q 14 Aug 2023 2023 Q2
Q4 2021 $3,049,706 $701,100 +$9,266 +1.3% 01 Oct 2021 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q3 2021 $3,040,440 $966,956 +$302,556 +46% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2022 Q3
Q2 2021 $2,737,884 $690,943 +$50,470 +7.9% 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022 2022 Q2
Q1 2021 $2,687,414 $690,707 +$43,594 +6.7% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q1
Q4 2020 $2,643,820 $691,834 +$33,431 +5.1% 01 Oct 2020 31 Dec 2020 10-K 30 Mar 2022 2021 FY
Q3 2020 $2,610,389 $664,400 -$12,995 -1.9% 01 Jul 2020 30 Sep 2020 10-Q 12 Nov 2021 2021 Q3
Q2 2020 $2,623,384 $640,473 -$122,002 -16% 01 Apr 2020 30 Jun 2020 10-Q 13 Aug 2021 2021 Q2
Q1 2020 $2,745,386 $647,113 -$125,748 -16% 01 Jan 2020 31 Mar 2020 10-Q 14 May 2021 2021 Q1
Q4 2019 $2,871,134 $658,403 +$104,833 +19% 01 Oct 2019 31 Dec 2019 10-K 26 Mar 2021 2020 FY
Q3 2019 $2,766,301 $677,395 -$265,160 -28% 01 Jul 2019 30 Sep 2019 10-Q 13 Nov 2020 2020 Q3
Q2 2019 $3,031,461 $762,475 -$57,047 -7% 01 Apr 2019 30 Jun 2019 10-Q 13 Aug 2020 2020 Q2
Q1 2019 $3,088,508 $772,861 -$55,088 -6.7% 01 Jan 2019 31 Mar 2019 10-Q 14 May 2020 2020 Q1
Q4 2018 $3,143,596 $553,570 -$257,439 -32% 01 Oct 2018 31 Dec 2018 10-K 30 Mar 2020 2019 FY
Q3 2018 $3,401,035 $942,555 +$162,699 +21% 01 Jul 2018 30 Sep 2018 10-Q 14 Nov 2019 2019 Q3
Q2 2018 $3,238,336 $819,522 +$49,064 +6.4% 01 Apr 2018 30 Jun 2018 10-Q 14 Aug 2019 2019 Q2
Q1 2018 $3,189,272 $827,949 +$63,335 +8.3% 01 Jan 2018 31 Mar 2018 10-Q 14 May 2019 2019 Q1
Q4 2017 $3,125,937 $811,009 01 Oct 2017 31 Dec 2017 10-K 28 Mar 2019 2018 FY
Q3 2017 $779,856 -$9,294 -1.2% 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2018 2018 Q3
Q2 2017 $770,458 -$151,525 -16% 01 Apr 2017 30 Jun 2017 10-Q 14 Aug 2018 2018 Q2
Q1 2017 $764,614 01 Jan 2017 31 Mar 2017 10-Q 14 May 2018 2018 Q1
Q3 2016 $789,150 01 Jul 2016 30 Sep 2016 10-Q 14 Nov 2017 2017 Q3
Q2 2016 $921,983 01 Apr 2016 30 Jun 2016 10-Q 14 Aug 2017 2017 Q2

CHINA PHARMA HOLDINGS, INC. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $2,170,820 -$359,037 -14% 01 Jan 2024 31 Dec 2024 10-K 31 Mar 2025 2024 FY
2023 $2,529,857 -$134,118 -5% 01 Jan 2023 31 Dec 2023 10-K 31 Mar 2025 2024 FY
2022 $2,663,975 -$385,731 -13% 01 Jan 2022 31 Dec 2022 10-K 01 Apr 2024 2023 FY
2021 $3,049,706 +$405,886 +15% 01 Jan 2021 31 Dec 2021 10-K 30 Mar 2023 2022 FY
2020 $2,643,820 -$227,314 -7.9% 01 Jan 2020 31 Dec 2020 10-K 30 Mar 2022 2021 FY
2019 $2,871,134 -$272,462 -8.7% 01 Jan 2019 31 Dec 2019 10-K 26 Mar 2021 2020 FY
2018 $3,143,596 +$17,659 +0.56% 01 Jan 2018 31 Dec 2018 10-K 30 Mar 2020 2019 FY
2017 $3,125,937 +$310,770 +11% 01 Jan 2017 31 Dec 2017 10-K 28 Mar 2019 2018 FY
2016 $2,815,167 -$465,451 -14% 01 Jan 2016 31 Dec 2016 10-K 02 Apr 2018 2017 FY
2015 $3,280,618 +$1,881,222 +134% 01 Jan 2015 31 Dec 2015 10-K 30 Mar 2016 2015 FY
2014 $1,399,396 01 Jan 2014 31 Dec 2014 10-K 30 Mar 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.